Guangzhou, November 23, 2024 – JinKangHeXin

Pharmaceutical shines at FIC 2024 Guangzhou Health Expo with its innovative MAGNAFOLATE, a patented active folate product, winning over industry experts and attendees with its superior efficacy and safety. A triumphant showcase for the brand!

About Magnafolate:

Magnafolate, Jinkang Hexin's patented active folate product, boasts over 40 globally licensed invention patents and has obtained the NDI market entry permit in the United States(NDI no. 920).

Key Features:

---C-Crystalline form for superior stability

---Supported by over three years of stability data

---Suitable for various climate zones

---Free from harmful raw materials like formaldehyde and p-toluenesulfonic acid

---Virtually non-toxic safety level

Magnafolate is the smart choice for active folate.

More questions, please inquire: info@magnafolate.com